UMIN-CTR Clinical Trial

Basic information
Public title	The Effect of test food (HBF 2018-03) on human vascular function. : Parallel study
Acronym	The Effect of test food (HBF 2018-03) on human vascular function.
Scientific Title	The Effect of test food (HBF 2018-03) on human vascular function. : Parallel study
Scientific Title:Acronym	The Effect of test food (HBF 2018-03) on human vascular function.
Region	Japan

Condition
Condition	Healthy adult
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To investigate the effect of the test food on vascular function
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	1. Vascular function
Key secondary outcomes	1. Skin blood flow 2. Skin surface temperature 3. Questionnaire survey on the physical condition 4. Skin composition

Base
Study type	Interventional

Study design
Basic design	Parallel
Randomization	Randomized
Randomization unit	Individual
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Treatment
Type of intervention	Food
Interventions/Control_1	Oral ingestion of the test food once a day for 8 weeks
Interventions/Control_2	Oral ingestion of the placebo food once a day for 8 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	65 years-old >
Gender	Female
Key inclusion criteria	1) Healthy Japanease adults
Key exclusion criteria	(1) Individuals with a disease under treatment now (2) Individuals who has been pregnantor subject who have a plan to become pregnant or breast feed during the study period (3) Individuals who consume exscessive smoking (4) Individuals who has metal allergy or adhesive allergy (5) Individuals who cannot follow orders from chief investigator or sub investigators (6) Individuals who are judged as inappropriate to be enrolled in this trials by chief investigator or sub investigators
Target sample size	20

Research contact person
Name of lead principal investigator	1st name Naoki Middle name Last name Morishita
Organization	Hayashibara Co., LTD.
Division name	R&D Division, Development Unit
Zip code	702-8006
Address	675-1 Fujisaki, Naka-ku, Okayama, Okayama
TEL	086-276-3141
Email	ogihara.saori@hb.nagase.co.jp

Public contact
Name of contact person	1st name Naoki Middle name Last name Morishita
Organization	Hayashibara Co., LTD.
Division name	R&D Division, Development Unit
Zip code	702-8006
Address	675-1 Fujisaki, Naka-ku, Okayama, Okayama
TEL	086-276-3141
Homepage URL
Email	ogihara.saori@hb.nagase.co.jp

Sponsor
Institute	Hayashibara Co., LTD.
Institute
Department

Funding Source
Organization	None
Organization
Division
Category of Funding Organization	Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	The Ethics Committee of Hayashibara Co.,Ltd.
Address	675-1, Fujisaki, Naka-ku, Okayama, Japan
Tel	086-276-3141
Email	HB96301@hb.nagase.co.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions	株式会社林原（岡山県） / Hayashibara Co., Ltd. (Okayama)

Other administrative information
Date of disclosure of the study information	2019 Year 01 Month 09 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled	20
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2018 Year 10 Month 26 Day
Date of IRB	2019 Year 10 Month 29 Day
Anticipated trial start date	2018 Year 12 Month 12 Day
Last follow-up date	2019 Year 03 Month 15 Day
Date of closure to data entry
Date trial data considered complete	2019 Year 09 Month 11 Day
Date analysis concluded

Other
Other related information

Management information
Registered date	2018 Year 12 Month 26 Day
Last modified on	2020 Year 01 Month 31 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040219